nucleus pulposus cell functions in IDD. These exciting findings suggest that specific modulation of lncRNAs or their downstream signalling pathways might be an attractive approach for developing novel therapeutics for IDD. extracellular matrix (ECM) components, such as aggrecan and type II collagen, and secretion of cytokines. [13] [14] [15] Importantly, deregulation of NP cell functions, including aberrant cell proliferation, apoptosis
and ECM synthesis/degradation have all been implicated in the development of IDD. 13, [16] [17] [18] [19] [20] Long non-coding RNAs (lncRNAs) are a group of non-coding RNAs which are longer than 200 nucleotides in length. Due to their long length, lncRNAs possess unique ability to adopt a variety of complex secondary and tertiary structures, allowing them to perform specific functions, such as catalysis, metabolite sensing and precise protein recognition. [21] [22] [23] [24] The predicted secondary structure of Xist, which is the best-characterised lncRNA to date, is shown in Figure 1 as an example of structural complexity of lncRNAs. LncRNAs have no or little capacity for protein coding, but could modulate gene expression at epigenetic (eg, DNA methylation, histone modification), transcriptional (eg, recruitment of transcriptional factors) and post-transcriptional (eg, sponging of microRNAs, regulation of mRNA stability) levels. [25] [26] [27] [28] [29] An increasing number of studies have demonstrated lncRNA deregulation in different kinds of morbidities, including neoplastic, inflammatory, infectious and orthopaedic diseases. [30] [31] [32] [33] [34] [35] As a key control of gene expression, lncRNAs play pivotal roles in regulating cellular phenotypes, including differentiation, apoptosis, proliferation, metabolism, migration and invasion. 29, [36] [37] [38] [39] Recently, some studies suggested that lncRNAs are critical players in the development of IDD. In this review article, we summarise the current knowledge regarding the deregulation of lncRNAs in IDD in relation to their effects on NP cell proliferation, apoptosis and ECM synthesis/degradation. The potential clinical utilities of lncRNAs as therapeutic targets for the management of IDD are also discussed.
F I G U R E 1 Predicted secondary structure of Xist, the best-characterised lncRNA to date (adapted from Wikimedia Commons) A total of 1854 lncRNAs were found to be differentially expressed with fold-change more than two, in which 1530 lncRNAs were predicted to target 6386 genes through cis-regulatory effects. KEGG pathway analysis for these target genes revealed that lncRNAs were involved in regulation of focal adhesion, lysosome function and mitogen-activated protein kinase (MAPK) signalling. Bioinformatic analysis of interactions among lncRNAs, microRNAs, and mRNAs suggested that the upregulated lncRNA PART1 might mediate the pathogenic effect via sponging miR-34a and miR-148a to derepress their corresponding target genes E2F3, VEGFA and ACVR1 in IDD.
| LncRNA E XPRE SS I ON PROFILING IN INTERVERTEB R AL D ISC DEG ENER ATI ON
The abovementioned studies have unequivocally demonstrated that lncRNA expression is significantly deregulated in degenerative IVD tissues and NP cells and strongly suggested that lncRNAs might be functionally involved in IDD pathogenesis (Table 1) .
Nevertheless, it is noteworthy that different studies have given rise to different results. For instance, the top 10 upregulated and downregulated lncRNAs identified in the RNA sequencing study by Zhao and colleagues 48 showed no overlap with the top deregulated lncRNAs (P < .05; fold-change > 10) identified in the microarray study by Wan and colleagues. 45 Whether the discrepancy arose as a result of the use of different clinical tissues or profiling platforms, however, is unclear.
| FUN C TI ONAL ROLE S OF LN CRNA S IN INTERVERTEB R AL D ISC DEG ENER ATI ON

| RP11-296A18.3
Aberrant proliferation of NP cells is implicated in IDD pathogenesis. 19 Wang and colleagues 49 the expression of collagen I and matrix metalloproteinase (MMP)-13.
Target prediction, RT-qPCR and luciferase assays further revealed that RP11-296A18.3 acted as a competing endogenous RNA for miR-138 and thereby derepressing its target HIF1A. In addition, the interrelationship among RP11-296A18.3, miR-138 and HIF1A was confirmed in human IDD tissues by immunochemistry and RT-qPCR.
These data indicated that RP11-296A18.3 promoted human NP cell proliferation and modulated ECM deposition via regulating the miR-138-HIF1A axis. These results also suggested that this lncRNA might be a therapeutic target in IDD.
| TUG1
Over-activation of Wnt/β-catenin signalling is casually linked to IDD development through multiple mechanisms, including induction of cellular senescence and abnormal ECM deposition/degradation.
50
The taurine upregulated gene 1 (TUG1) is a newly identified lncRNA frequently upregulated in human malignancies 30 and mechanistically linked to Wnt/β-catenin activation. 51 Chen and colleagues The pro-senescence, pro-apoptotic and ECM-modulating effects of TUG1 overexpression were blocked by the Wnt/β-catenin inhibitor XAV-939. Knockdown of TUG1 produced the opposite effects.
These data suggested that aberrant upregulation of TUG1 in NP cells resulted in senescence, apoptosis and suppression of ECM synthesis through the Wnt/β-catenin pathway. Targeting TUG1 might thus be a potential therapeutic strategy for the treatment of IDD.
| HCG18
Xi and colleagues 53 demonstrated that the expression of the lncRNA HCG18 (HLA complex group 18) transcribed from chromosome 6 was significantly upregulated in NP tissues isolated from patients with herniated or bulging discs and was positively associated with the grade of disc degeneration. Mechanistically, HCG18 was found to function as an endogenous sponge for miR-146a-5p to inhibit cell proliferation, promote cell apoptosis, and enhance release of chemoattractants for macrophages in NP cells. Conversely, knockout of miR-146a-5p expression produced the opposite effects.
Mechanistically, TRAF6, an upstream positive regulator of nuclear factor (NF)-κB signalling and a direct target gene of miR-146a-5p, and phosphorylation of NF-κB p65 at Serine 536 were found to be upregulated upon HCG18 overexpression. The positive correlation between HCG18 and TRAF6 expression was also confirmed in clinical NP tissues. To this end, knockdown of TRAF6 by small hairpin RNA reversed HCG18-induced NP proliferative arrest and apoptosis. These results suggested that aberrant overexpression of HCG18 might promote IDD development through inducing human NP cell death via derepressing the TRAF6-NFκB pathway that is normally inhibited by miR-146a-5p.
| MALAT1
MALAT1 (metastasis associated lung adenocarcinoma transcript 1) also known as NEAT2 is a lncRNA with physiological functions in different cellular processes, including alternative splicing, nuclear organisation and epigenetic modulation of gene expression. 54 Zhang and colleagues 55 
| SNHG1
Small nucleolar RNA host gene 1 (SNHG1) is a host to eight small nu- These results suggested that the lncRNA SNHG1 played a crucal role in IDD development through inducing aberrant NP cell proliferation.
| H19
H19 is an imprinted oncofoetal lncRNAs with high expression levels during embryogenesis but is nearly undetectable in most adult tissues. 59 Wang and colleagues 60 region to alleviate its inhibition on LEF1, which is a transcription factor required for β-catenin-driven transcription of Wnt target genes.
| NEAT1
NEAT1 (nuclear paraspeckle assembly transcript 1) is a novel lncRNA localised specifically to nuclear paraspeckles and its overexpression has been documented in many human malignancies. 61 Ruan and colleagues 62 F I G U R E 2 Deregulation of intracellular signalling and functions of nucleus pulposus cells by lncRNAs in intervertebral disc degeneration
| linc-ADAMTS5
Inflammation has been linked to increased aggrecan degradation in IDD. 63 Wang and colleagues 64 (Table 2 ).
| CON CLUS ION
Intervertebral disc degeneration is a common pathogenic process underlying low back pain. However, its molecular and cellular patho- 
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